5-HT2a receptor agonists therapy (Virginia Commonwealth University)

N/A

Report date: 2024/01/09 17:52:14

Base Information

Drug Name5-HT2a receptor agonists therapy (Virginia Commonwealth University)
Drug Alias Name5-HT2A-mGlu2 Receptor Complex(Virginia Commonwealth University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor agonists
TargetsSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirginia Commonwealth University
China Registration ClassN/A

Develop Information

Active CompaniesVirginia Commonwealth University
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A